The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
TRIS AMINO HCl is widely used as a diagnostic reagent and as a downstream processing buffer in the purification of commercial biopharmaceuticals
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
